Human Papillomavirus Vaccine Safety in Pediatric Patients: An Evaluation of the Vaccine Adverse Event Reporting System

被引：12

作者：

Borja-Hart, Nancy L. ^{[1
]}

Benavides, Sandra ^{[1
]}

Christensen, Crystal ^{[1
]}

机构：

[1] Nova SE Univ, Coll Pharm, Ft Lauderdale, FL 33328 USA

来源：

ANNALS OF PHARMACOTHERAPY | 2009年 / 43卷 / 02期

关键词：

Gardasil; human papillomavirus; pediatrics; VAERS; PARTICLE VACCINE; QUADRIVALENT VACCINE; UNITED-STATES; TYPE-16; IMMUNOGENICITY; ADOLESCENTS; TRIAL; WOMEN;

D O I：

10.1345/aph.1L492

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Recent news reports have linked the human papillomavirus (HPV) vaccine to serious adverse events (AEs) in children and adolescents. We used the Vaccine Adverse Event Reporting System (VAERS) database to extract postmarketing AEs reported in patients who received the vaccine. Since approval of the HPV vaccine in the US, 3174 AEs occurring in children and adolescents (aged 6-17 y) have been reported to the VAERS. Of these, 191 (6%) were deemed to be serious. Although these AEs are of significant concern, more research is required before they can be directly correlated with the vaccine.

引用

页码：356 / 359

页数：4

共 50 条

[21] Signal detection for vaccine safety in the vaccine adverse event reporting system using change point models
Huang, Jing
Du, Jingcheng
Ellenberg, Susan S.
Hennessy, Sean
Tao, Cui
Chen, Yong
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 451 - 452
[22] Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system
Woo, Emily Jane
Moro, Pedro L.
VACCINE, 2021, 39 (13) : 1812 - 1817
[23] Quantitative Vaccine Safety Signal Detection Techniques Using Vaccine Adverse Event Reporting System (VAERS)
Liang, Huifang
Sakaguchi, Motonobu
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 238 - 238
[24] Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
Woo, Emily Jane
Moro, Pedro L.
Cano, Maria
Jankosky, Christopher
VACCINE, 2017, 35 (42) : 5618 - 5621
[25] HUMAN PAPILLOMAVIRUS VACCINE:ADVERSE EVENTS REPORTED TO THE US VACCINE ADVERSE EVENTS REPORTING SYSTEM (2010-2019)
Preciado, S. M.
Rodriguez-Monguio, R.
Seoane-Vazquez, E.
VALUE IN HEALTH, 2020, 23 : S178 - S178
[26] Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System
Arana, Jorge
Mba-Jonas, Adamma
Jankosky, Christopher
Lewis, Paige
Moro, Pedro L.
Shimabukuro, Tom T.
Cano, Maria
JOURNAL OF ADOLESCENT HEALTH, 2017, 61 (05) : 577 - 582
[27] Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System
Tatang, Collins
Arredondo Bisono, Teigna
Bergamasco, Aurore
Salvo, Francesco
Costa Clemens, Sue Ann
Moride, Yola
DRUGS-REAL WORLD OUTCOMES, 2022, 9 (01) : 79 - 90
[28] Human Papillomavirus Vaccination and Premature Ovarian Failure: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System
Collins Tatang
Teigna Arredondo Bisonó
Aurore Bergamasco
Francesco Salvo
Sue Ann Costa Clemens
Yola Moride
Drugs - Real World Outcomes, 2022, 9 : 79 - 90
[29] Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
Sever, JL
Brenner, AI
Gale, AD
Lyle, JM
Moulton, LH
West, DJ
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (03) : 189 - 202
[30] Detecting Signals in the Vaccine Adverse Event Reporting System
Broder, Karen
Haber, Penina
Miller, Elaine
DeStefano, Frank
Vellozzi, Claudia
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S358 - S358

← 1 2 3 4 5 →